[1]
Fontana, P., Alberio, L., Albisetti, M., Angelillo-Scherrer, A., Asmis, L.M., Casini, A., Gerber, B., Graf, L., Hegemann, I., Korte, W., Martinez, M., Studt, J.-D., Tsakiris, D.A., Wuillemin, W.A. and Kremer Hovinga, J.A. 2020. Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab: A consensus statement of the Working Party on Haemostasis of the Swiss Society of Haematology and the Swiss Haemophilia Network. Swiss Medical Weekly. 150, 5153 (Dec. 2020), w20422. DOI:https://doi.org/10.4414/smw.2020.20422.